The significance of this regulation of Exo1 by FOXM1 in DDR is highlighted by the revelation that FOXM1 modulates the sensitivity to the DNA-damaging agents, cisplatin and doxorubicin, through regulating EXO1 in ovarian and breast cancer, respectively [27], [73]. Here, EXO1 is linked to breast carcinoma.